SMAD4 and metabolic dysfunction-associated steatotic liver disease: In this study, we demonstrated that hepatocyte Smad4 expression stimulated CXCL1 secretion via the ASK1, P38 MAPK, and JNK signaling pathways, thereby promoting the progression of NAFLD.